BioVaxys Technology Corp. (CSE:BIOV)

Canada · Delayed Price · Currency is CAD

0.0700

+0.0100 (16.67%)

May 5, 2026, 3:55 PM EST

BioVaxys Technology Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Net Income	-5.99	-3.95	-7.69	-11.73	-6.46	-1.17
Asset Writedown & Restructuring Costs	1.29	1.29	1.45	7.4	-	-
Stock-Based Compensation	0.33	0.3	3.25	0.62	1.25	0.35
Other Operating Activities	-0.65	0.45	-0.25	0.23	-0	0.07
Change in Accounts Payable	1.68	0.69	1.8	1.98	-0.5	0.18
Change in Other Net Operating Assets	0.38	-0.64	0.39	-0.07	0.42	-0.63
Operating Cash Flow	-2.97	-1.86	-1.05	-1.57	-5.29	-1.23
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Cash Acquisitions	-	-	-	-	-	0.04
Sale (Purchase) of Intangibles	-	-1.06	-	-	-	-
Other Investing Activities	-	-	-	-	-	0.02
Investing Cash Flow	-	-1.06	-	-	-	0.06

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Short-Term Debt Repaid	-	-0.03	-	-	-	-
Total Debt Repaid	-0.03	-0.03	-	-	-	-
Net Debt Issued (Repaid)	-0.05	-0.03	-	-	-	-
Issuance of Common Stock	2.53	3.16	0.92	1.13	3.78	3.33
Other Financing Activities	-	-	-	-0.03	-0.34	0.02
Financing Cash Flow	2.48	3.13	0.92	1.11	3.44	3.35

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Foreign Exchange Rate Adjustments	0	0	-0	0.02	0.03	0.01
Net Cash Flow	-0.49	0.21	-0.14	-0.45	-1.83	2.19

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Levered Free Cash Flow	-1.03	-4.01	4.06	-0.74	-2.71	-0.06
Unlevered Free Cash Flow	-1.03	-4.01	4.06	-0.74	-2.71	-0.06

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Change in Working Capital	2.06	0.05	2.19	1.9	-0.08	-0.45